MUC16 and cancer: Biomarkers such as prostate-specific antigen (PSA), cancer-antigen 125 (CA-125), and carcinoembryonic antigen (CEA) [8] are commonly sought-after detection targets that allow healthcare specialists to loosely attribute the upregulation of these biomarkers to the presence of cancers in the body.